Navigation Links
Study demonstrates link between reclassification of cannabis and cannabis psychosis
Date:7/18/2013

Researchers from the University of York have demonstrated that the change in cannabis declassification in 2009 has coincided with a significant increase in hospital admissions for cannabis psychosis - rather than the decrease it was intended to produce.

The UK Misuse of Drugs Act (1971) divided controlled drugs into three groups A, B and C with descending criminal sanctions attached to each class. Cannabis was originally assigned to Group B, but in 2004, it was transferred to the lowest risk group, Group C.

In 2009, on the basis of increasing concerns about a link between high strength cannabis and schizophrenia, it was moved back to Group B.

Researchers from the University's Department of Health Sciences examined admissions to psychiatric hospitals in England between 1999 and 2010 to explore whether the reclassifications in 2004 and 2009 were associated with changes in the admissions rate for cannabis psychosis.

They found that there was a significantly increasing trend in admissions from 1999 to 2004, but following the reclassification of cannabis from B to C in 2004, there was a decline until 2009. Following the second reclassification back to class B in 2009, there was once again a significant increase in admissions.

The study was led by Ian Hamilton from York's Department of Health Sciences, an expert on the relationship between substance misuse and mental health. The results are published in the International Journal of Drug Policy.

Psychosis describes a range of symptoms, such as distortions of reality, hearing voices, difficulty in thinking and problems with motivation.

Ian Hamilton said: "Our research shows an interesting relationship between the Government's decision to reclassify cannabis and the rate of hospital admissions for cannabis psychosis. It is significant as the Government's argument for reclassification was made on the basis that the stronger forms of cannabis known as 'skunk' are more likely to lead to mental health problems such as psychosis. However, our research challenges this.

"While our study shows a statistical association between the reclassification of cannabis and hospital admissions for cannabis psychosis, it is in the opposite direction to that predicated by the presumed relationship between the two."

The authors say the reasons for the statistical association between the reclassification of cannabis and hospital admissions for cannabis psychosis are unclear.

Ian Hamilton said: "The association is unlikely to be due to changes in cannabis use over this period, but possible explanations include changes in policing and systematic changes in mental health services unrelated to classification decisions."


'/>"/>

Contact: Caron Lett
caron.lett@york.ac.uk
44-019-043-22029
University of York
Source:Eurekalert

Related medicine news :

1. Spectrum Health study first to identify heart attack-causing plaque in living patients
2. TGen-TD2-Scottsdale Healthcare breast cancer pilot study shows value of proteomic mapping
3. Study of Vanuatu Further Identifies Behaviors That Cause Obesity
4. Study reveals new dietary risk factors for colorectal cancer
5. Undiagnosed pre-diabetes highly prevalent in early Alzheimers disease study
6. Pradaxa Lawsuit News: Bernstein Liebhard LLP Notes New Study Linking Pradaxa to Increased Heart Attack Risk
7. Advanced Medical Certification Offers Audiobooks and PDF Study Guides at No Cost Upon Course Purchase
8. Biomarker Market is Estimated to Grow at a CAGR of 14.40% During the Study Period of 2011-2016 – New Report by MarketsandMarkets
9. Besttoolbars Study Reveals New Trend in Online Cashback Marketing
10. Study finds strong pregnancy outcomes for survivors of childhood cancer
11. Study finds potential markers for severity of childhood arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... Those ... deal with these feelings, many turn to unhealthy avenues, such as drug or alcohol ... of Marne, Michigan, has released tools for healthy coping following a traumatic event. , ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, ... and the Road To Recovery® program to drive cancer patients to and from their ... to ensure the highest quality of life and ongoing independence. Getting to and ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
Breaking Medicine Technology: